- Home
- CATX vs HRZN Comparison
CATX vs HRZN Comparison
Compare CATX & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATX
- HRZN
- Stock Information
- Founded
- CATX 1983
- HRZN 2008
- Country
- CATX United States
- HRZN United States
- Employees
- CATX N/A
- HRZN N/A
- Industry
- CATX Medical/Dental Instruments
- HRZN Finance/Investors Services
- Sector
- CATX Health Care
- HRZN Finance
- Exchange
- CATX Nasdaq
- HRZN Nasdaq
- Market Cap
- CATX 239.0M
- HRZN 251.0M
- IPO Year
- CATX N/A
- HRZN 2010
- Fundamental
- Price
- CATX $2.73
- HRZN $6.57
- Analyst Decision
- CATX Strong Buy
- HRZN Hold
- Analyst Count
- CATX 10
- HRZN 4
- Target Price
- CATX $12.30
- HRZN $7.38
- AVG Volume (30 Days)
- CATX 1.7M
- HRZN 733.3K
- Earning Date
- CATX 11-10-2025
- HRZN 10-28-2025
- Dividend Yield
- CATX N/A
- HRZN 22.80%
- EPS Growth
- CATX N/A
- HRZN N/A
- EPS
- CATX N/A
- HRZN N/A
- Revenue
- CATX $1,235,000.00
- HRZN $98,899,000.00
- Revenue This Year
- CATX N/A
- HRZN N/A
- Revenue Next Year
- CATX N/A
- HRZN $9.61
- P/E Ratio
- CATX N/A
- HRZN N/A
- Revenue Growth
- CATX N/A
- HRZN N/A
- 52 Week Low
- CATX $1.60
- HRZN $5.71
- 52 Week High
- CATX $12.90
- HRZN $10.10
- Technical
- Relative Strength Index (RSI)
- CATX 35.35
- HRZN 62.76
- Support Level
- CATX $2.85
- HRZN $5.81
- Resistance Level
- CATX $3.15
- HRZN $5.96
- Average True Range (ATR)
- CATX 0.47
- HRZN 0.16
- MACD
- CATX -0.17
- HRZN 0.08
- Stochastic Oscillator
- CATX 0.75
- HRZN 90.58
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.